GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS

Title:

GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS

Document Type and Number:

Japanese Patent JP2018134089

Kind Code:

A

Abstract:

PROBLEM TO BE SOLVED: To provide improved binding compounds that are fully human and specifically bind to gram-positive bacteria.SOLUTION: The invention provides isolated antibodies that have the ability to bind to all gram-positive bacteria selected from the group consisting of S. aureus, S. faecalis, S. pyogenes, S. epidermidis, and B. licheniformis, and do not bind to S. pneumonia or S. mutans.SELECTED DRAWING: None

More Like This:

JPH02231431	UTILIZATION OF FC FRAGMENT OF HUMAN IGG, PEPTIDE ANALOGOUS TO FC FRAGMENT, OR HUMAN IGG FOR OBTAINING PHARMACEUTICAL PREPARATION TO DOSE HUMAN WITH MONOCLONAL ANTIBODY FOR PURPOSE OF MEDICAL TREATMENT OR DIAGNOSIS
WO/2023/016505	IL-11 HUMANIZED ANTIBODY AND APPLICATION THEREOF
WO/2001/094585	ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN TUMOR NECROSIS FACTOR ALPHA, AND USE THEREOF

Inventors:

TIM BEAUMONT
MARK JEROEN KWAKKENBOS
ERIC J BROWN
JOHN HIROSHI MORISAKI
WOUTER L W HAZENBOS
SANJEEV MARIATHASAN
KIMBERLY KAJIHARA
XIA YI

Application Number:

JP2018072444A

Publication Date:

August 30, 2018

Filing Date:

April 04, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

AIMM THERAPEUTICS BV
GENENTECH INC

International Classes:

C12N15/13; A61K31/7088; A61K39/02; A61K39/085; A61K39/09; A61K39/395; A61K48/00; A61P31/04; A61P37/04; C07K16/12; C12N1/02; C12N1/15; C12N1/19; C12N1/20; C12N1/21; C12N5/10; C12P21/08; C12Q1/68; G01N33/569

Attorney, Agent or Firm:

Sonoda/Kobayashi Patent Business Corporation

Previous Patent: 組換え弱毒化パルボウイルス

Next Patent: Ｔ細胞エピトープを含む、Ｂ細胞受容体複合体結合タンパク質